TXNL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. TXNL Gen Silencer sind erhältlich als TXNL CRISPR/Cas9 Knockout Plasmide und TXNL Double Nickase Plasmide. TXNL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
TXNL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TXNL1 CRISPR/Cas9 KO Plasmid (h) | sc-407201 | h | Gene Knockout | GFP | 0 | ||
TXNL1 HDR Plasmid (h) | sc-407201-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TXNL1 Double Nickase Plasmid (h) | sc-407201-NIC | h | Gene Knockout | Puromycin | 0 | ||
TXNL1 Double Nickase Plasmid (h2) | sc-407201-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TXNL1 CRISPR/Cas9 KO Plasmid (m) | sc-424705 | m | Gene Knockout | GFP | 0 | ||
TXNL1 HDR Plasmid (m) | sc-424705-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TXNL1 Double Nickase Plasmid (m) | sc-424705-NIC | m | Gene Knockout | Puromycin | 0 | ||
TXNL1 Double Nickase Plasmid (m2) | sc-424705-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TXNL6 CRISPR/Cas9 KO Plasmid (h) | sc-408546 | h | Gene Knockout | GFP | 0 | ||
TXNL6 HDR Plasmid (h) | sc-408546-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TXNL6 Double Nickase Plasmid (h) | sc-408546-NIC | h | Gene Knockout | Puromycin | 0 | ||
TXNL6 Double Nickase Plasmid (h2) | sc-408546-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TXNL6 CRISPR/Cas9 KO Plasmid (m) | sc-433363 | m | Gene Knockout | GFP | 0 | ||
TXNL6 HDR Plasmid (m) | sc-433363-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TXNL6 Double Nickase Plasmid (m) | sc-433363-NIC | m | Gene Knockout | Puromycin | 0 | ||
TXNL6 Double Nickase Plasmid (m2) | sc-433363-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TXNL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TXNL1 CRISPR Activation Plasmid (h) | sc-407201-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 CRISPR Activation Plasmid (h2) | sc-407201-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 Lentiviral Activation Particles (h) | sc-407201-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 Lentiviral Activation Particles (h2) | sc-407201-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 CRISPR Activation Plasmid (m) | sc-424705-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 CRISPR Activation Plasmid (m2) | sc-424705-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 Lentiviral Activation Particles (m) | sc-424705-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL1 Lentiviral Activation Particles (m2) | sc-424705-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 CRISPR Activation Plasmid (h) | sc-408546-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 CRISPR Activation Plasmid (h2) | sc-408546-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 Lentiviral Activation Particles (h) | sc-408546-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 Lentiviral Activation Particles (h2) | sc-408546-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 CRISPR Activation Plasmid (m) | sc-433363-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 CRISPR Activation Plasmid (m2) | sc-433363-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 Lentiviral Activation Particles (m) | sc-433363-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TXNL6 Lentiviral Activation Particles (m2) | sc-433363-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |